ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0890

Replicating the Human Leukocyte Antigen (HLA)-Independent Association of Non-HLA Donor/Recipient Genomic Mismatches with Kidney Allograft Survival in a Contemporary Cohort

Session Information

Category: Transplantation

  • 2101 Transplantation: Basic

Authors

  • Oberbauer, Rainer, Medical University of Vienna, Department of Nephrology & Dialysis, Vienna, Austria
  • Kammer, Michael, Medical University of Vienna, Department of Nephrology & Dialysis, Vienna, Austria
  • Heinzel, Andreas, Medical University of Vienna, Department of Nephrology & Dialysis, Vienna, Austria
  • Reindl-Schwaighofer, Roman, Medical University of Vienna, Department of Nephrology & Dialysis, Vienna, Austria
  • Shoebridge, Stephen, Medical University of Vienna, Department of Nephrology & Dialysis, Vienna, Austria
  • Hu, Karin, Medical University of Vienna, Department of Nephrology & Dialysis, Vienna, Austria
  • Kainz, Alexander, Medical University of Vienna, Department of Nephrology & Dialysis, Vienna, Austria
  • Niemann, Matthias, Pirche AG, Berlin, Germany
Background

In 2019 we published for the first time the HLA mismatch (HLA-MM) independent association of non-HLA donor/recipient (D/R) genomic mismatches (non-HLA-MM) with graft survival in first deceased donor kidney transplants. Here we replicate this finding in a larger contemporary cohort.

Methods

We utilized the Vienna Kidney Transplant Cohort, a prospective open cohort study initiated in 2012. From 2012 - 2023, a total of 1,680 transplants were performed and 854 recipients of a first deceased donor transplant were available for the replication. Two-field HLA-typing and whole exome sequencing (WES) were performed. WES data were processed into annotated SNPs with GATK and Ensembl Variant Effect Predictor. Subcellular location was used to restrict to immune-accessible proteins and the number of non-synonymous SNP mismatches was determined. For HLA-MM PIRCHE-T2 scores were computed on 5 HLA loci. The association of non-HLA and HLA scores with death censored graft failure was evaluated using Kaplan-Meier (KM) analysis and Cox proportional hazard models.

Results

The median recipient and donor ages were 58 and 57 years, respectively. Among recipients 34% were female. In the follow up period 117 grafts were lost and 256 recipients died. KM analysis of high and low non-HLA-MM stratified by the median showed reduced graft survival for higher mismatch load (Fig 1a). Analysis of the continuous score in a Cox model adjusted for key predictors of graft survival confirmed the HLA-MM independent association of the non-HLA-MM score with graft survival (Fig 1b). The strength of association of non-HLA and HLA-MM per interquartile range with graft survival were similar to our previous study.

Conclusion

We successfully replicated the findings from our index study regarding the association between non-HLA-MM and graft survival. This once more highlights that in addition to HLA compatibility non-HLA D/R compatibility plays an important role in transplantation success.

Digital Object Identifier (DOI)